Matthew Arnold's most recent trade in Solid Biosciences Inc was a trade of 432,432 Common Stock done at an average price of $3.7 . Disclosure was reported to the exchange on Dec. 10, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Solid Biosciences Inc | Matthew Arnold | Director | Grant, award, or other acquisition of securities at price $ 3.70 per share. | 10 Dec 2020 | 432,432 | 3,933,429 (8%) | 0% | 3.7 | 1,599,998 | Common Stock |
Solid Biosciences Inc | Matthew Arnold | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 30,000 | 30,000 | - | - | Director Stock Option (Right to Buy) |